Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Clinical trial NCT01844505 · COMPLETED
Trial details
- NCT number
- NCT01844505
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-11
- Primary completion
- 2016-08-01
- Enrollment
- 945
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.